2021 Revenues ($USD) : $24,391,094,000
2021 Revenues (foreign currencies) : €20,618,000,000
2021 R&D spend : $4,882,241,000
2021 Number of Employees : 52,391
Fiscal Year End : 12/31/2021
Leader : Chair Hubertus von Baumbach

Ingelheim, Germany–based Boehringer Ingelheim remains the world’s largest private pharmaceutical company. Founded in 1885, Boehringer Ingelheim got its start making ingredients for baking powder and carbonated beverages. It presently has significant human health, animal health and contract manufacturing divisions. Currently, the company has approximately 100 drug candidates in its pre-clinical and clinical development. It has more than 60 new molecular entities in its portfolios. It has 20 potential new medicine approvals in its pipeline over the next seven years. Key commercialized drugs include Jardiance, Spiriva, Tarjenta/Jentadueto and Pradaxa. —BB